Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
25%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
1
9%
Ph not_applicable
3
27%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Terminated(2)
Other(1)

Detailed Status

Completed8
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
N/A3 (60.0%)

Trials by Status

terminated19%
withdrawn19%
unknown19%
completed873%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11